SpyGlass Pharma, Inc. (SGP) Free cash flow 2024–2025
SpyGlass Pharma, Inc. (SGP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$33.5MFY2025 · since FY2024: -$24.0M → -$33.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.5M | -39.4% |
| FY2024 | -$24.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice